PH-762
PHIO-762-2301
Phase 1 small_molecule active
Quick answer
PH-762 for Squamous Cell Carcinoma of the Skin is a Phase 1 program (small_molecule) at Phio Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Phio Pharmaceuticals
- Indication
- Squamous Cell Carcinoma of the Skin
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active